In preclinical studies, it has been demonstrated to cause orofacial allodynia and increase neuronal activity within the trigeminovascular system (TVS) [45,46], captivatingly 41% of migraineurs have been shown to experience migraine-like episodes after using pramlintide, an amylin analogue [45]. The gene discussed is IAPP; the disease is migraine disorder.